ClinicalTrials.gg

Syntimmune, Inc. clinical trials

Acquired by AstraZeneca, Jul 21, 2021 · source ↗

The registry lists 1 studies whose lead sponsor is Syntimmune, Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 24, 2018.

Before and after it joined AstraZeneca

First submitted before Syntimmune, Inc. became part of AstraZeneca
1
First submitted after Syntimmune, Inc. became part of AstraZeneca
0
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Syntimmune, Inc.’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.

Studies, none open

All 1 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed1100%

Phase

  • Early Phase 11

Where

  • United States1

Over the years

  1. 116
  2. 17
  3. 18
  4. 19
  5. 20
  6. 21
  7. 22
  8. 23
  9. 24
  10. 25
  11. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Syntimmune, Inc.1 study

Something wrong with this grouping? Tell us on the AstraZeneca page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All AstraZeneca studies →